Genetic behavioral screen identifies an orphan anti-opioid system
Author(s) -
Dandan Wang,
Hannah M. Stoveken,
Stefano Zucca,
Maria Dao,
Cesare Orlandi,
Chenghui Song,
Ikuo Masuho,
Caitlin Johnston,
Karla J. Opperman,
Andrew C. Giles,
Matthew S. Gill,
Erik A. Lundquist,
Brock Grill,
Kirill A. Martemyanov
Publication year - 2019
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.aau2078
Subject(s) - heterotrimeric g protein , opioid , μ opioid receptor , opioid receptor , g protein , pharmacology , chemical genetics , caenorhabditis elegans , neuroscience , g protein coupled receptor , signal transduction , biology , receptor , microbiology and biotechnology , genetics , gene , small molecule
Opioids target the μ-opioid receptor (MOR) to produce unrivaled pain management, but their addictive properties can lead to severe abuse. We developed a whole-animal behavioral platform for unbiased discovery of genes influencing opioid responsiveness. Using forward genetics in Caenorhabditis elegans , we identified a conserved orphan receptor, GPR139, with anti-opioid activity. GPR139 is coexpressed with MOR in opioid-sensitive brain circuits, binds to MOR, and inhibits signaling to heterotrimeric guanine nucleotide-binding proteins (G proteins). Deletion of GPR139 in mice enhanced opioid-induced inhibition of neuronal firing to modulate morphine-induced analgesia, reward, and withdrawal. Thus, GPR139 could be a useful target for increasing opioid safety. These results also demonstrate the potential of C. elegans as a scalable platform for genetic discovery of G protein-coupled receptor signaling principles.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom